Drug Type Small molecule drug |
Synonyms TAK 441 |
Target |
Action antagonists |
Mechanism SMO antagonists(Smoothened receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC28H31F3N4O6 |
InChIKeyZADWXQMNNVICKB-UHFFFAOYSA-N |
CAS Registry1186231-83-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 01 Oct 2010 | |
Basal Cell Carcinoma | Phase 1 | United States | 01 Oct 2010 | |
Solid tumor | Phase 1 | United States | - |